Abstract
The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression.
Roy A Fava, Sarah Elliott, Lauren Raymond, Jessica Mollmark, Ezra Hays, Tadashi Honda, Gordon W Gribble, Michael B Sporn and Matthew P Vincenti
The Journal of Rheumatology May 2007, 34 (5) 1058-1068;
Roy A Fava
Sarah Elliott
Lauren Raymond
Jessica Mollmark
Ezra Hays
Tadashi Honda
Gordon W Gribble
Michael B Sporn
In this issue
The Journal of Rheumatology
Vol. 34, Issue 5
1 May 2007
The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression.
Roy A Fava, Sarah Elliott, Lauren Raymond, Jessica Mollmark, Ezra Hays, Tadashi Honda, Gordon W Gribble, Michael B Sporn, Matthew P Vincenti
The Journal of Rheumatology May 2007, 34 (5) 1058-1068;
The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression.
Roy A Fava, Sarah Elliott, Lauren Raymond, Jessica Mollmark, Ezra Hays, Tadashi Honda, Gordon W Gribble, Michael B Sporn, Matthew P Vincenti
The Journal of Rheumatology May 2007, 34 (5) 1058-1068;